Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Rowley et al v. AbbVie Inc et al
Case Number:
1:15-cv-02760
Court:
Nature of Suit:
367(Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability)
Judge:
Firms
Companies
Sectors & Industries:
-
June 14, 2018
AbbVie Wins 5th Bellwether In Testosterone MDL
An Illinois federal jury found for AbbVie Inc. on Thursday in a trial over claims its drug AndroGel caused a man's deep vein thrombosis, handing the company a win in the fifth bellwether trial in the testosterone replacement therapy multidistrict litigation.
-
June 05, 2018
AbbVie Wore 'Blinders' On AndroGel's Clot Risk, Jury Told
AbbVie Inc. had "blinders" on when it came to AndroGel's risk of blood clots, counsel for a man who had a deep vein thrombosis while taking the testosterone replacement therapy drug told an Illinois federal jury Tuesday.